Prenetics Global Limited(PRE)Earnings, Financials & Key Ratios
PRE•NASDAQ
Price updated Jun 19, 2026
AboutPrenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring system that allows users to take COVID-19 tests at point-of-care or at home utilizing the nucleic acid amplification test. The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an off-the-shelf at-home blood test; Circle Medical, a diagnostic testing product; and Circle One and F1x/Fem. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.Show more
- Revenue$92M+201.7%
- EBITDA-$34M+18.6%
- Net Income-$38M+18.6%
- EPS (Diluted)-2.68+26.4%
- Gross Margin52.81%+5.0%
- EBITDA Margin-37.18%+73.0%
- Operating Margin-41.27%+73.8%
- Net Margin-40.81%+73.0%
- ROE-21.81%+10.2%
PRE Key Insights
Prenetics Global Limited (PRE) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Company is almost debt free
✗Weaknesses
- ✗Profits declining 81.0% over 5 years
- ✗Negative free cash flow
- ✗Shares diluted 10.6% in last year
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when PRE posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
PRE Price & Volume
Prenetics Global Limited (PRE) stock price & volume — 10-year historical chart
Loading chart...
PRE Growth Metrics
Prenetics Global Limited (PRE) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years7.23%
3 Years91.46%
TTM173.96%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-47.61%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-20.21%
Return on Capital
10 Years-45.83%
5 Years-39.96%
3 Years-22.77%
Last Year-21.61%
PRE Recent Earnings
Prenetics Global Limited (PRE) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 5/12 qtrs (45%)●Beat Revenue 4/12 qtrs (36%)
Q3 2026Latest
Jun 10, 2026Metric
Actual
Est
EPS
$0.56-14.3%
$0.49
Rev
$36M-0.1%
$36M
Q2 2026
May 14, 2026Metric
Actual
Est
EPS
$1.14-131.6%
$0.49
Rev
$36M-2.3%
$37M
Q1 2026
Feb 18, 2026Metric
Actual
Est
EPS
$0.27+44.9%
$0.49
Rev
$37M+9.5%
$33M
Q4 2025
Nov 10, 2025Metric
Actual
Est
EPS
$0.41+25.5%
$0.55
Rev
$24M-38.5%
$38M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q3 2026Latest | Jun 10, 2026 | $0.56vs $0.49-14.3% | $36Mvs $36M-0.1% |
| Q2 2026 | May 14, 2026 | $1.14vs $0.49-131.6% | $36Mvs $37M-2.3% |
| Q1 2026 | Feb 18, 2026 | $0.27vs $0.49+44.9% | $37Mvs $33M+9.5% |
| Q4 2025 | Nov 10, 2025 | $0.41vs $0.55+25.5% | $24Mvs $38M-38.5% |
Based on last 12 quarters of dataView full earnings history →
PRE Peer Comparison
Prenetics Global Limited (PRE) competitors in Point-of-Care and Rapid Testing — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 EXAS | 20.02B | 104.91 | -95.37 | 17.69% | -6.4% | -8.66% | 1.05 | |
 NTRA | 33.14B | 231.41 | -152.24 | 35.9% | -9.05% | -15.13% | 0.13 | |
 CSTL | 640.57M | 21.12 | -25.45 | 3.66% | -3.77% | -2.77% | 0.08 | |
 QDEL | 930.68M | 13.67 | -0.82 | -1.89% | -45.57% | -56.31% | 1.46 | |
 AHCO | 1.31B | 9.65 | -18.56 | -0.49% | -2.78% | -5.09% | 1.25 | |
 HIMS | 7.79B | 35.47 | 69.55 | 59% | -0.56% | -2.48% | 2.34 | |
 MYRG | 7.18B | 461.10 | 61.24 | 8.79% | 3.71% | 22.14% | 0.16 | |
 TMO | 172.66B | 464.61 | 26.19 | 3.91% | 15.18% | 13.23% | 0.76 |
Compare PRE vs Peers
Prenetics Global Limited (PRE) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
PRE Income Statement
Prenetics Global Limited (PRE) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 9.23M | 65.18M | 12.53M | 13.16M | 21.74M | 30.62M | 92.39M | 113.75M |
Revenue Growth % | - | 605.93% | -80.77% | 5.04% | 65.17% | 40.83% | 201.72% | 173.96% |
Cost of Goods Sold | 6.52M | 38.83M | 8.93M | 9.55M | 12.91M | 15.22M | 43.6M | 47.41M |
COGS % of Revenue | 70.59% | 59.58% | 71.25% | 72.52% | 59.39% | 49.71% | 47.19% | - |
Gross Profit | 2.72M▲ 0% | 26.34M▲ 870.2% | 3.6M▼ 86.3% | 3.62M▲ 0.4% | 8.83M▲ 144.1% | 15.4M▲ 74.4% | 48.79M▲ 216.8% | 66.34M▲ 0% |
Gross Margin % | 29.41% | 40.42% | 28.75% | 27.48% | 40.61% | 50.29% | 52.81% | 58.32% |
Gross Profit Growth % | - | 870.24% | -86.33% | 0.43% | 144.05% | 74.41% | 216.82% | - |
Operating Expenses | 23.52M | 27.34M | 60.26M | 69.64M | 60.74M | 63.54M | 86.92M | 104.66M |
OpEx % of Revenue | 254.72% | 41.95% | 480.86% | 529.02% | 279.34% | 207.52% | 94.08% | - |
Selling, General & Admin | 17.96M | 23.11M | 53.67M | 64.08M | 49.68M | 55.37M | 79.8M | 95.47M |
SG&A % of Revenue | 194.46% | 35.45% | 428.24% | 486.79% | 228.5% | 180.81% | 86.37% | - |
Research & Development | 2.99M | 2.78M | 6.39M | 5.99M | 11.66M | 10.92M | 5.13M | 4.57M |
R&D % of Revenue | 32.38% | 4.27% | 51% | 45.5% | 53.64% | 35.67% | 5.55% | - |
Other Operating Expenses | 2.57M | 1.45M | 202.18K | -430K | -606.84K | -2.75M | 1.99M | 801K |
Operating Income | -20.8M▲ 0% | -995.13K▲ 95.2% | -56.66M▼ 5593.9% | -66.02M▼ 16.5% | -51.91M▲ 21.4% | -48.14M▲ 7.2% | -38.13M▲ 20.8% | -38.33M▲ 0% |
Operating Margin % | -225.31% | -1.53% | -452.11% | -501.53% | -238.73% | -157.23% | -41.27% | -33.69% |
Operating Income Growth % | - | 95.22% | -5593.94% | -16.52% | 21.38% | 7.25% | 20.8% | - |
EBITDA | -18.57M | 1.43M | -49.32M | -58.48M | -44.11M | -42.22M | -34.35M | -35.74M |
EBITDA Margin % | -201.11% | 2.2% | -393.49% | -444.23% | -202.88% | -137.86% | -37.18% | -31.42% |
EBITDA Growth % | - | 107.71% | -3546.42% | -18.58% | 24.57% | 4.3% | 18.64% | 36.29% |
D&A (Non-Cash Add-back) | 2.23M | 2.43M | 7.35M | 7.54M | 7.79M | 5.93M | 3.78M | 3.97M |
EBIT | -20.8M | -3.84M | -216.51M | -225.58M | -55.69M | -57.5M | -35.97M | -55.64M |
Net Interest Income | -53.88K | -51.52K | -42.03K | 230K | 3.8M | 1.84M | 801K | -174K |
Interest Income | 15.51K | 8.04K | 201 | 472K | 3.92M | 2.04M | 1.04M | 0 |
Interest Expense | 69.39K | 59.57K | 42.23K | 242K | 119.66K | 203K | 241K | 174K |
Other Income/Expense | -69.39K | -2.91M | -159.89M | -159.8M | -4.76M | -9.56M | 1.92M | -35.09M |
Pretax Income | -20.87M▲ 0% | -3.9M▲ 81.3% | -216.55M▼ 5450.6% | -225.82M▼ 4.3% | -56.67M▲ 74.9% | -57.7M▼ 1.8% | -36.21M▲ 37.2% | -73.41M▲ 0% |
Pretax Margin % | -226.06% | -5.99% | -1727.9% | -1715.44% | -260.63% | -188.44% | -39.2% | -64.54% |
Income Tax | -677.47K | -1.94M | 2.57M | -245K | -269.36K | -7.87M | 34K | 47K |
Effective Tax Rate % | 3.25% | 49.66% | -1.19% | 0.11% | 0.48% | 13.65% | -0.09% | -0.06% |
Net Income | -20.14M▲ 0% | -1.94M▲ 90.4% | -174.01M▼ 8871.0% | -190.45M▼ 9.5% | -62.72M▲ 67.1% | -46.3M▲ 26.2% | -37.71M▲ 18.6% | -71.04M▲ 0% |
Net Margin % | -218.15% | -2.98% | -1388.44% | -1446.78% | -288.48% | -151.22% | -40.81% | -62.45% |
Net Income Growth % | - | 90.37% | -8870.99% | -9.45% | 67.07% | 26.18% | 18.56% | -47.61% |
Net Income (Continuing) | -20.2M | -1.96M | -219.12M | -225.58M | -56.4M | -49.83M | -36.25M | -73.46M |
Discontinued Operations | 0 | 0 | 45.11M | 35.12M | -8.38M | 22K | -3.73M | -744K |
Minority Interest | -53.21K | -77.41K | -84.97K | 6.4M | 3.8M | 957K | -93K | -93K |
EPS (Diluted) | -2.73▲ 0% | -0.26▲ 90.5% | -47.04▼ 17992.3% | -37.57▲ 20.1% | -5.58▲ 85.1% | -3.64▲ 34.8% | -2.68▲ 26.4% | -4.18▲ 0% |
EPS Growth % | - | 90.48% | -17992.31% | 20.13% | 85.15% | 34.77% | 26.37% | -20.21% |
EPS (Basic) | -2.73 | -0.26 | -47.04 | -37.57 | -5.58 | -3.64 | -2.68 | - |
Diluted Shares Outstanding | 7.4M | 7.4M | 3.7M | 5.07M | 11.25M | 12.71M | 14.05M | 16.98M |
Basic Shares Outstanding | 7.4M | 7.4M | 3.7M | 5.07M | 11.25M | 12.71M | 14.05M | 16.98M |
Dividend Payout Ratio | - | - | - | - | - | - | - | - |
PRE Balance Sheet
Prenetics Global Limited (PRE) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|
Total Current Assets | 15.63M | 43.96M | 106.89M | 241.81M | 93.66M | 86.15M | 83.39M | 132.11M |
Cash & Short-Term Investments | 11.82M | 14.8M | 45.19M | 184.12M | 72.74M | 62.81M | 61.49M | 106.03M |
Cash Only | 11.52M | 14.49M | 35.29M | 146.66M | 45.71M | 52.25M | 32.13M | 56.02M |
Short-Term Investments | 294.06K | 314.71K | 9.91M | 37.46M | 27.03M | 10.56M | 29.36M | 50.02M |
Accounts Receivable | 2.89M | 23.1M | 47.05M | 42.5M | 5.29M | 5.61M | 2.98M | 11.88M |
Days Sales Outstanding | 114.34 | 129.34 | 1.37K | 1.18K | 88.87 | 66.81 | 11.78 | 21.39 |
Inventory | 547.85K | 4.5M | 6.83M | 4.53M | 3.13M | 6.57M | 7.06M | 14.2M |
Days Inventory Outstanding | 30.68 | 42.27 | 279.13 | 173.36 | 88.39 | 157.45 | 59.07 | 59.46 |
Other Current Assets | 374.36K | 979.6K | 7.31M | 4.58M | 8.31M | 3.55M | 11.86M | 0 |
Total Non-Current Assets | 14.06M | 34.93M | 41.61M | 70.32M | 160.51M | 127.43M | 120.13M | 43.19M |
Property, Plant & Equipment | 2.11M | 4.69M | 13.04M | 13.1M | 5.78M | 7.81M | 1.76M | 594K |
Fixed Asset Turnover | 4.37x | 13.89x | 0.96x | 1.00x | 3.76x | 3.92x | 52.40x | 62.22x |
Goodwill | 3.85M | 3.99M | 3.98M | 33.8M | 29.17M | 37.36M | 0 | 0 |
Intangible Assets | 6.27M | 23.96M | 23.83M | 14.79M | 13.43M | 11.57M | 44.7M | 40K |
Long-Term Investments | 1.66M | 0 | 0 | 788.47K | 107.84M | 69.33M | 67M | 204.5M |
Other Non-Current Assets | 161K | 2.28M | 693.55K | 7.6M | 4.27M | 1.35M | 6.68M | 40.22M |
Total Assets | 29.69M▲ 0% | 78.88M▲ 165.7% | 148.51M▲ 88.3% | 312.13M▲ 110.2% | 254.17M▼ 18.6% | 213.57M▼ 16.0% | 203.52M▼ 4.7% | 175.3M▲ 0% |
Asset Turnover | 0.31x | 0.83x | 0.08x | 0.04x | 0.09x | 0.14x | 0.45x | 0.59x |
Asset Growth % | - | 165.72% | 88.26% | 110.18% | -18.57% | -15.97% | -4.71% | -50.09% |
Total Current Liabilities | 11.9M | 47.07M | 58.74M | 57.2M | 39.48M | 36.55M | 27.67M | 25.64M |
Accounts Payable | 2.76M | 13.44M | 9.98M | 7.29M | 1.67M | 3.67M | 7.72M | 1.96M |
Days Payables Outstanding | 154.61 | 126.29 | 407.9 | 278.78 | 47.23 | 87.96 | 64.67 | 39.58 |
Short-Term Debt | 0 | 15.47M | 1.67M | 0 | 0 | 0 | 1.33M | 0 |
Deferred Revenue (Current) | 0 | 0 | 9.59M | 5.67M | 6.11M | 6.49M | 3.09M | 19.86M |
Other Current Liabilities | 7.79M | 10.92M | 22.64M | 17.47M | 15.49M | 15.07M | 15.5M | 0 |
Current Ratio | 1.31x | 0.93x | 1.82x | 4.23x | 2.37x | 2.36x | 3.01x | 5.15x |
Quick Ratio | 1.27x | 0.84x | 1.70x | 4.15x | 2.29x | 2.18x | 2.76x | 4.60x |
Cash Conversion Cycle | -9.6 | 45.32 | 1.24K | 1.07K | 130.03 | 136.31 | 6.18 | 41.27 |
Total Non-Current Liabilities | 930.56K | 804.57K | 490.66M | 11.47M | 4.53M | 5.68M | 1.34M | 28.64M |
Long-Term Debt | 124.32K | 0 | 486.4M | 0 | 0 | 0 | 437K | 0 |
Capital Lease Obligations | 775.23K | 804.57K | 3.6M | 3.76M | 867K | 3.01M | 437K | 2.21M |
Deferred Tax Liabilities | 0 | 0 | 659.5K | 3.19M | 2.62M | 2.17M | 8K | 26K |
Other Non-Current Liabilities | 31.01K | 0 | 0 | 4.52M | 1.05M | 499K | 460K | 28.58M |
Total Liabilities | 12.83M | 47.88M | 549.4M | 68.67M | 44.01M | 42.23M | 29.01M | 54.28M |
Total Debt | 1.46M | 17.14M | 491.67M | 6.65M | 2.37M | 5.77M | 2.2M | 457K |
Net Debt | -10.07M | 2.65M | 456.38M | -140.01M | -43.34M | -46.48M | -29.93M | -55.56M |
Debt / Equity | 0.09x | 0.55x | - | 0.03x | 0.01x | 0.03x | 0.01x | 0.00x |
Debt / EBITDA | - | 11.98x | - | - | - | - | - | -0.01x |
Net Debt / EBITDA | - | 1.86x | - | - | - | - | - | 1.55x |
Interest Coverage | -299.80x | -64.50x | -5127.08x | -932.14x | -465.40x | -283.25x | -149.26x | -319.79x |
Total Equity | 16.85M▲ 0% | 31.01M▲ 84.0% | -400.89M▼ 1392.9% | 243.46M▲ 160.7% | 210.16M▼ 13.7% | 171.35M▼ 18.5% | 174.51M▲ 1.8% | 121.02M▲ 0% |
Equity Growth % | - | 83.99% | -1392.92% | 160.73% | -13.68% | -18.47% | 1.85% | -54.53% |
Book Value per Share | 2.28 | 4.19 | -108.37 | 48.03 | 18.69 | 13.49 | 12.42 | 7.13 |
Total Shareholders' Equity | 16.91M | 31.08M | -400.81M | 237.06M | 206.36M | 170.39M | 174.6M | 121.11M |
Common Stock | 45.69M | 15.35M | 1.49K | 13.7K | 18K | 19K | 25K | 25K |
Retained Earnings | -41.64M | -43.58M | 0 | -408.04M | -470.77M | -517.07M | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | -661.52K | -62K | -639K | 0 | 0 |
Accumulated OCI | 12.86M | 21.42M | -400.81M | -185.69M | -176.03M | -169.25M | 0 | 121.09M |
Minority Interest | -53.21K | -77.41K | -84.97K | 6.4M | 3.8M | 957K | -93K | -93K |
PRE Cash Flow Statement
Prenetics Global Limited (PRE) cash flow — operating, investing & free cash flow history
| Metric | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|
Cash from Operations | -1.88M | -2.88M | 13.42M | 14.51M | -13.76M | -28.87M | -21.81M | -33.94M |
Operating CF Margin % | -20.4% | -4.42% | 107.05% | 110.26% | -63.31% | -94.29% | -23.61% | - |
Operating CF Growth % | - | -52.92% | 565.9% | 8.18% | -194.84% | -109.77% | 24.46% | 0% |
Net Income | -20.2M | -1.96M | -174.02M | -190.45M | -64.78M | -49.81M | -52.7M | -71.04M |
Depreciation & Amortization | 2.23M | 2.43M | 7.35M | 7.54M | 7.79M | 5.93M | 3.78M | 3.97M |
Stock-Based Compensation | 3.91M | 1.62M | 22.49M | 31.58M | 10.59M | 11.98M | 0 | 141K |
Deferred Taxes | -677.47K | -1.94M | 3.73M | 7.15M | -385.84K | -7.87M | 0 | 28K |
Other Non-Cash Items | 2.64M | 4.77M | 160.45M | 192.46M | 8.8M | 8.93M | 20.48M | 24.95M |
Working Capital Changes | 10.21M | -7.79M | -6.59M | -33.76M | 24.21M | 1.97M | 6.62M | 2.39M |
Change in Receivables | 1.83M | -20.09M | -24.06M | 6.97M | 37.63M | -428K | -529K | -74K |
Change in Inventory | 415.69K | -3.75M | -2.33M | 1.26M | -1.73M | 1.32M | -3.38M | -10.52M |
Change in Payables | 1.71M | 9.71M | -3.46M | -2.63M | -5.62M | -4.68M | 4.91M | 3.73M |
Cash from Investing | -4.6M | -5.97M | -22.02M | -46.14M | -82.95M | 38.54M | -35.79M | 13.63M |
Capital Expenditures | -373.86K | -3.06M | -8.55M | -6.34M | -345.29K | -1.01M | -54.56M | -54.56M |
CapEx % of Revenue | 4.05% | 4.69% | 68.2% | 48.18% | 1.59% | 3.29% | 59.06% | 47.97% |
Acquisitions | -4.24M | -2.93M | 0 | -3.42M | 0 | 21.65M | 37.77M | 106.78M |
Investments | - | - | - | - | - | - | - | - |
Other Investing | 12.43K | 14.75K | -3.47M | 531.99K | -76.52M | 2.02M | 1000K | 1.29M |
Cash from Financing | -569.14K | 11.84M | 29.32M | 143.32M | -4.7M | -3.34M | 37.54M | 24.27M |
Debt Issued (Net) | -503.58K | -610.93K | -1.3M | -1.88M | -3.23M | -2.56M | 40.15M | 40.01M |
Equity Issued (Net) | 0 | 0 | 25.97M | -661.52K | -1.23M | -577K | 2K | -13.12M |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | 0 | 0 | 0 | -661.52K | -1.23M | -577K | 0 | -13.12M |
Other Financing | -65.55K | 12.45M | 4.65M | 145.86M | -241.5K | -203K | -2.61M | -2.62M |
Net Change in Cash | -7.26M▲ 0% | 2.97M▲ 140.9% | 20.8M▲ 600.7% | 111.37M▲ 435.5% | -100.95M▼ 190.6% | 6.54M▲ 106.5% | -20.12M▼ 407.4% | 21.32M▲ 0% |
Free Cash Flow | -2.26M▲ 0% | -5.94M▼ 163.2% | 2M▲ 133.7% | 8.17M▲ 307.7% | -14.68M▼ 279.6% | -29.94M▼ 104.0% | -22.02M▲ 26.5% | -34.14M▲ 0% |
FCF Margin % | -24.44% | -9.11% | 15.99% | 62.08% | -67.5% | -97.77% | -23.83% | -30.02% |
FCF Growth % | - | -163.17% | 133.74% | 307.73% | -279.6% | -103.99% | 26.45% | - |
FCF per Share | -0.31 | -0.80 | 0.54 | 1.61 | -1.31 | -2.36 | -1.57 | -2.01 |
FCF Conversion (FCF/Net Income) | 0.09x | 1.48x | -0.08x | -0.08x | 0.22x | 0.62x | 0.58x | 0.48x |
Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
PRE Key Ratios
Prenetics Global Limited (PRE) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | -8.11% | - | -78.23% | -27.65% | -24.27% | -21.81% | -46.76% |
Return on Invested Capital (ROIC) | -3.69% | -95.34% | -62.31% | -28.81% | -24.76% | -21.23% | -23.17% |
Gross Margin | 40.42% | 28.75% | 27.48% | 40.61% | 50.29% | 52.81% | 58.32% |
Net Margin | -2.98% | -1388.44% | -1446.78% | -288.48% | -151.22% | -40.81% | -62.45% |
Debt / Equity | 0.55x | - | 0.03x | 0.01x | 0.03x | 0.01x | 0.00x |
Interest Coverage | -64.50x | -5127.08x | -932.14x | -465.40x | -283.25x | -149.26x | -319.79x |
FCF Conversion | 1.48x | -0.08x | -0.08x | 0.22x | 0.62x | 0.58x | 0.48x |
Revenue Growth | 605.93% | -80.77% | 5.04% | 65.17% | 40.83% | 201.72% | 173.96% |
Related:PRE Dividend History·PRE Revenue History·PRE Price History·PRE P/E History·PRE Financial Ratios·PRE Institutional Holders
PRE Frequently Asked Questions
Prenetics Global Limited (PRE) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Prenetics Global Limited (PRE) reported $113.7M in revenue for fiscal year 2025. This represents a 1132% increase from $9.2M in 2019.
Prenetics Global Limited (PRE) grew revenue by 201.7% over the past year. This is strong growth.
Prenetics Global Limited (PRE) reported a net loss of $71.0M for fiscal year 2025.
Dividend & Returns
Prenetics Global Limited (PRE) has a return on equity (ROE) of -21.8%. Negative ROE indicates the company is unprofitable.
Prenetics Global Limited (PRE) had negative free cash flow of $34.1M in fiscal year 2025, likely due to heavy capital investments.